变构调节
小脑
泛素连接酶
化学
背景(考古学)
化学生物学
连接器
计算生物学
细胞生物学
生物物理学
泛素
功能(生物学)
药物发现
蛋白质功能
血浆蛋白结合
效应器
生物化学
DNA连接酶
变构酶
小分子
蛋白质结构
分子药理学
融合蛋白
信号转导衔接蛋白
内吞循环
超家族
分子开关
生物
配体(生物化学)
基质(水族馆)
结合位点
泛素蛋白连接酶类
靶蛋白
化学空间
蛋白质结构域
蛋白质-蛋白质相互作用
作者
Vanessa N. Dippon,Christina M. Woo
标识
DOI:10.1021/acscentsci.6c01187
摘要
Allostery modulates protein function through domains that are distinct from a protein’s orthosteric active site. In a therapeutic context, allosteric ligands provide mechanisms to overcome resistance, improve selectivity, and act cooperatively with orthosteric ligands. Separately, induced proximity modalities alter protein function by inducing an interaction between a target protein and an effector protein, like the E3 ligase substrate adapter cereblon (CRBN), which promotes the proteasomal degradation of the target. CRBN ligands that bind at the thalidomide-binding domain have seeded versatile chemical platforms for molecular glue degraders and proteolysis-targeting chimeras (PROTACs). CRBN gains its remarkable inducible substrate scope through conformational shifts that can be mediated by allosteric ligands to alter protein degradation outcomes. We merge the intersection of allostery with induced proximity modalities by examining it first in the context of allosteric pharmacology and second in the context of targeted protein degradation with CRBN, highlighting how lessons learned from allostery with other therapeutic targets could inform emerging opportunities for allosteric modulation of induced proximity events. This intersection of allostery and induced proximity at CRBN conceptually unites two major chemical means of changing protein fate, bringing the potential for highly selective and potent chemical modalities for a greater part of the proteome closer to reality.
科研通智能强力驱动
Strongly Powered by AbleSci AI